RPM

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

Retrieved on: 
木曜日, 5月 9, 2024
Health, Technology, Diabetes, Health Technology, Managed Care, Software, Consensus, American Diabetes Association, Physician, Electronic health record, RPM, Safety, Blood pressure, EHR, CGM, Partnership, Doctor of Philosophy, Type 2 diabetes, Patient, Practitioner, Remote patient monitoring, Medical device

Powered by Rimidi, the Eversense CGM + RPM solution is intended to seamlessly and securely push patient glucose data to the most widely used EHR systems, to provide direct access for healthcare providers.

Key Points: 
  • Powered by Rimidi, the Eversense CGM + RPM solution is intended to seamlessly and securely push patient glucose data to the most widely used EHR systems, to provide direct access for healthcare providers.
  • “The Eversense RPM Program™ is the next step in our roadmap to combine long-term implantable CGM technology with advanced analytics and personalized health services into a comprehensive diabetes solution.
  • Eversense RPM will arm providers with powerful data to optimize care in between office visits where 99% of diabetes management takes place,” said Tim Goodnow, PhD, President and Chief Executive Officer of Senseonics.
  • A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.

Validic named “Best Remote Patient Monitoring Solution” in 8th Annual MedTech Breakthrough Awards Program

Retrieved on: 
木曜日, 5月 9, 2024
Medtech, Glycated hemoglobin, RPM, Ecosystem, SBP, Health, Cardiology, EHR, Electronic health record, Telehealth, Medical device, Patient, Hypertension, Remote patient monitoring, Nursing

DURHAM, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- Validic Inc. , a market-leading digital health and personalized care company, today announced it has been selected as “Best Remote Patient Monitoring Solution” in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.

Key Points: 
  • DURHAM, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- Validic Inc. , a market-leading digital health and personalized care company, today announced it has been selected as “Best Remote Patient Monitoring Solution” in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.
  • “Validic exceeds these expectations, with a breakthrough solution that puts patient data where clinicians need it, and it fits within their existing care models.
  • Blending in-person and remote care, as well as personal health data from devices, ultimately creates a new standard of care.
  • We extend our sincere congratulations to the Validic team on their well-deserved 2024 MedTech Breakthrough Award.”

XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS

Retrieved on: 
火曜日, 5月 7, 2024
RPM, Ecosystem, Health, EHR, Stel, Himawari (satellites), Wi-Fi, PHI, Patient, Privacy, Behavior

Xealth’s integration into the EHR brings the Stel program into clinical workflows, ensuring that providers have instant access to important health data.

Key Points: 
  • Xealth’s integration into the EHR brings the Stel program into clinical workflows, ensuring that providers have instant access to important health data.
  • Additionally, as an extra privacy measure, Stel’s integration with Xealth is implemented without health systems sharing PHI with Stel.
  • “We’re privileged to support innovative health systems in evolving care to the home and improving the overall health of the communities they serve,” said Sid Kandan, CEO of Stel Life.
  • We don’t need to know exactly who the patient is, but trust Xealth to get data to records.”
    Stel Life seamlessly and securely connects wireless health devices to care teams using cellular networks that function even in areas with low broadband access.

PERI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Perion Network Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
火曜日, 5月 7, 2024
RPM, ChatGPT, News, Risk, Microsoft Bing, Complaint, Growth, Microsoft, Court, Advertising, Person

Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/PERI .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/PERI .
  • According to the Complaint, Perion is a global technology company that provides digital advertising solutions to brands, agencies, and publishers in North America, Europe, and internationally.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

Perion Reports First Quarter 2024 Results; YoY Revenue Growth of 9%

Retrieved on: 
水曜日, 5月 8, 2024
Technology, Other Communications, Marketing, Advertising, Communications, Audio, Video, Software, Networks, Digital Marketing, RPM, CTV, Microsoft, EPS, Search advertising, Contribution, Share repurchase, Adjustment, Dilution, GAAP, Bank

Revenue: Revenue increased by 9% to $157.8 million in the first quarter of 2024 from $145.2 million in the first quarter of 2023.

Key Points: 
  • Revenue: Revenue increased by 9% to $157.8 million in the first quarter of 2024 from $145.2 million in the first quarter of 2023.
  • Traffic Acquisition Costs and Media Buy (“TAC”): TAC amounted to $97.6 million, or 62% of revenue, in the first quarter of 2024, compared with $79.9 million, or 55% of revenue, in the first quarter of 2023.
  • GAAP Net Income: GAAP net income decreased by 51% to $11.8 million in the first quarter of 2024, compared with $23.8 million, in the first quarter of 2023.
  • Non-GAAP Net Income: Non-GAAP net income decreased by 25% to $22.6 million, or 14% of revenue, in the first quarter of 2024, compared with $29.9 million, or 21% of revenue, in the first quarter of 2023.

Vivalink Launches Turnkey Ambulatory Cardiac Monitoring Solution for MCT and Holter

Retrieved on: 
水曜日, 5月 8, 2024
Cardiovascular disease, Mortality, Health, RPM, Algorithm, MCT, ECG

CAMPBELL, Calif., May 8, 2024 /PRNewswire/ -- With cardiovascular disease being a leading cause of mortality worldwide, Vivalink, a leading provider of digital healthcare solutions, announces the launch of its comprehensive technology solution designed for Mobile Cardiac Telemetry (MCT) and Holter monitoring. The solution integrates remote patient monitoring (RPM) technologies and advanced arrhythmia detection algorithms, streamlining deployment and enhancing patient care to meet the increasing demand for efficient ambulatory ECG monitoring solutions. By using a common technology solution for both MCT and Holter, partners can streamline the delivery and reduce the cost of ambulatory cardiac monitoring services.

Key Points: 
  • The solution integrates remote patient monitoring (RPM) technologies and advanced arrhythmia detection algorithms, streamlining deployment and enhancing patient care to meet the increasing demand for efficient ambulatory ECG monitoring solutions.
  • By using a common technology solution for both MCT and Holter, partners can streamline the delivery and reduce the cost of ambulatory cardiac monitoring services.
  • "Our integrated solution simplifies the deployment of remote cardiac monitoring services, offering a seamless implementation for our partners."
  • Attendees can experience the ambulatory cardiac monitoring technology solution firsthand.

Harris Healthcare's Esrun Health and PatchRx Partner to Infuse "Last Mile of Care" Technology with Unparalleled Insights into Patient Medication Adherence

Retrieved on: 
火曜日, 5月 7, 2024
RPM, CCM, Risk, Health, RTM, Partnership, Medicine, Patient, Adherence (medicine), Remote patient monitoring, Death, Chronic care management, COVID-19, Nursing

NIAGARA FALLS, N.Y. and TULSA, Okla., May 7, 2024 /PRNewswire/ -- Esrun Health, a division of Harris Healthcare that is redefining virtual care through innovative technologies and a customized model of remote care services, and PatchRx, the company revolutionizing patient care through its patented medication adherence technology, today announced a collaboration to give providers a more holistic view of remote patient care. Coupling Esrun's remote care ecosystem and PatchRx's innovative medication management technology and utilization data creates a unified care management suite of solutions and services that delivers crucial insight into a patient's receptiveness to prescribed therapy and medication adherence behaviors – empowering providers to improve treatment outcomes.

Key Points: 
  • Poor medication adherence is blamed for up to 25 percent of hospitalizations and approximately 125,000 U.S. deaths annually .
  • Yet most healthcare providers lack the data and tools needed to glean valuable insights into patients' compliance with prescribed medication therapy.
  • The Esrun Health-PatchRx collaboration closes this gap by giving providers a comprehensive view of patients' medication use.
  • PatchRx is thrilled to collaborate with Esrun Health to deliver one of the industry's only end-to-end remote care solutions," he adds.

Remote Patient Monitoring Market to Be Worth $116.84 Billion by 2031 - Exclusive Report by Meticulous Research®

Retrieved on: 
月曜日, 5月 6, 2024
Telehealth, World Health Organization, Partnership, Abbott Laboratories, Intelligence, Medtronic, Privacy, Boston Scientific, Prevalence, WHO, Dexcom, Machine learning, Literacy, Vital signs, Omron, Wearable computer, Blood pressure, Ageing, Diabetes, Conditional sentence, RPM, Fear, Artificial intelligence, Function, Incidence, Geography, Blood, DSM-IV codes, Health care, Patient, Mechanical ventilation, Oracle Corporation, COVID-19, Growth, Medical device

Thus, the integration of AI in remote patient monitoring is expected to improve patient experience, boosting the adoption of remote patient monitoring solutions.

Key Points: 
  • Thus, the integration of AI in remote patient monitoring is expected to improve patient experience, boosting the adoption of remote patient monitoring solutions.
  • Geographically, in 2024, North America is expected to account for the largest share of 44% of the remote patient monitoring market.
  • The North America remote patient monitoring market is estimated to be worth USD 21.2 billion in 2024.
  • The global remote patient monitoring market has witnessed product launches, product approvals, collaborations, acquisitions, and expansions in the last couple of years.

Remote Patient Monitoring Market to Be Worth $116.84 Billion by 2031 - Exclusive Report by Meticulous Research®

Retrieved on: 
月曜日, 5月 6, 2024
Telehealth, World Health Organization, Partnership, Abbott Laboratories, Intelligence, Medtronic, Privacy, Boston Scientific, Prevalence, WHO, Dexcom, Machine learning, Literacy, Vital signs, Omron, Wearable computer, Blood pressure, Ageing, Diabetes, Conditional sentence, RPM, Fear, Artificial intelligence, Function, Incidence, Geography, Blood, DSM-IV codes, Health care, Patient, Mechanical ventilation, Oracle Corporation, COVID-19, Growth, Medical device

Thus, the integration of AI in remote patient monitoring is expected to improve patient experience, boosting the adoption of remote patient monitoring solutions.

Key Points: 
  • Thus, the integration of AI in remote patient monitoring is expected to improve patient experience, boosting the adoption of remote patient monitoring solutions.
  • Geographically, in 2024, North America is expected to account for the largest share of 44% of the remote patient monitoring market.
  • The North America remote patient monitoring market is estimated to be worth USD 21.2 billion in 2024.
  • The global remote patient monitoring market has witnessed product launches, product approvals, collaborations, acquisitions, and expansions in the last couple of years.

Smart Meter Introduces World’s First Cellular-Enabled Glucose Meter with Notifications and Multi-Language Capabilities

Retrieved on: 
日曜日, 5月 5, 2024
Mobile, Wireless, Technology, Medical Devices, Diabetes, Health Technology, Telemedicine, Virtual Medicine, Other Health, Biometrics, Biotechnology, Health, RPM, Pharmacy, Smart, Smart meter, Life, Smartphone, Blood, Patient, LED, Physician, American Telemedicine Association, Multimedia, Patient satisfaction, Howard University, Telehealth, Medical device

iGlucose Plus is available with Spanish language on-screen prompts providing improved access to care to a largely underserved patient population.

Key Points: 
  • iGlucose Plus is available with Spanish language on-screen prompts providing improved access to care to a largely underserved patient population.
  • (Photo: Business Wire)
    The iGlucose Plus is an innovative glucose meter that is easy to use and requires no synching, pairing, smartphone, or Wi-Fi.
  • The new iGlucose Plus is an excellent example of that,” said Casey Pittock, CEO of Smart Meter.
  • The new iGlucose Plus will be on display at the American Telemedicine Association show in Phoenix, Arizona May 5 – 7 at Smart Meter’s booth #1007.